PharmaRoth Labs (PharmaRoth Labs) Days Payable : 41.06 (As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Days Payable?

PharmaRoth Labs's average Accounts Payable for the three months ended in Mar. 2011 was $0.05 Mil. PharmaRoth Labs's Cost of Goods Sold for the three months ended in Mar. 2011 was $0.12 Mil. Hence, PharmaRoth Labs's Days Payable for the three months ended in Mar. 2011 was 41.06.

The historical rank and industry rank for PharmaRoth Labs's Days Payable or its related term are showing as below:

ROTH's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.12
* Ranked among companies with meaningful Days Payable only.

PharmaRoth Labs's Days Payable increased from Mar. 2010 (0.00) to Mar. 2011 (41.06). It may suggest that PharmaRoth Labs delayed paying its suppliers.

PharmaRoth Labs Days Payable Historical Data

The historical data trend for PharmaRoth Labs's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Days Payable Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Days Payable

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Days Payable	Get a 7-Day Free Trial											-	-	-	-	41.06

Competitive Comparison of PharmaRoth Labs's Days Payable

For the Biotechnology subindustry, PharmaRoth Labs's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaRoth Labs's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Days Payable distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Days Payable falls into.

PharmaRoth Labs Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PharmaRoth Labs's Days Payable for the fiscal year that ended in Jun. 2010 is calculated as

	Days Payable (A: Jun. 2010 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2009 )	+	Accounts Payable (A: Jun. 2010 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2010 )	*	Days in Period
=	( (0.01	+	0.006)	/	2 )	/	0	*	365
=	0.008					/	0	*	365
=	N/A

PharmaRoth Labs's Days Payable for the quarter that ended in Mar. 2011 is calculated as:

	Days Payable (Q: Mar. 2011 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2010 )	+	Accounts Payable (Q: Mar. 2011 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2011 )	*	Days in Period
=	( (0.029	+	0.079)	/	2 )	/	0.12	*	365 / 4
=	0.054					/	0.12	*	365 / 4
=	41.06

PharmaRoth Labs Days Payable Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022